{"id":"https://openalex.org/W1992801434","doi":"https://doi.org/10.1016/j.pharep.2014.06.003","title":"Antiproliferative effect induced by novel imidazoline S43126 in PC12 cells is mediated by ROS, stress activated MAPKs and caspases","display_name":"Antiproliferative effect induced by novel imidazoline S43126 in PC12 cells is mediated by ROS, stress activated MAPKs and caspases","alternate_titles":[],"publication_year":2014,"publication_date":"2014-06-23","ids":{"openalex":"https://openalex.org/W1992801434","doi":"https://doi.org/10.1016/j.pharep.2014.06.003","mag":"1992801434","pmid":"https://pubmed.ncbi.nlm.nih.gov/25443718"},"language":"en","primary_location":{"id":"doi:10.1016/j.pharep.2014.06.003","doi":"https://doi.org/10.1016/j.pharep.2014.06.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.pharep.2014.06.003","pdf_url":null,"source":{"id":"https://openalex.org/S180401253","display_name":"Pharmacological Reports","issn_l":"1734-1140","issn":["1734-1140","2299-5684"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Reports","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1992801434"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017616460","display_name":"Lancelot Stuart McLean","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26347476","display_name":"Loma Linda University","ror":"https://ror.org/04bj28v14","country_code":"US","type":"education","lineage":["https://openalex.org/I26347476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lancelot S. McLean","raw_affiliation_strings":["Center for Dental Research, Loma Linda University School of Dentistry, Loma Linda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Dental Research, Loma Linda University School of Dentistry, Loma Linda, United States","institution_ids":["https://openalex.org/I26347476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111982641","display_name":"Louis J. Crane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Louis Crane","raw_affiliation_strings":["Facult\u00e9 des Sciences Pharmaceutiques, Laboratoire de Chimie Pharmaceutique, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facult\u00e9 des Sciences Pharmaceutiques, Laboratoire de Chimie Pharmaceutique, Toulouse, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059200627","display_name":"Genevi\u00e8ve Baziard","orcid":"https://orcid.org/0000-0002-6762-9167","observed_orcids":["https://orcid.org/0000-0002-6762-9167"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Genevieve Baziard-Mouysset","raw_affiliation_strings":["Facult\u00e9 des Sciences Pharmaceutiques, Laboratoire de Chimie Pharmaceutique, Toulouse, France"],"raw_orcid":"https://orcid.org/0000-0002-6762-9167","affiliations":[{"raw_affiliation_string":"Facult\u00e9 des Sciences Pharmaceutiques, Laboratoire de Chimie Pharmaceutique, Toulouse, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020840963","display_name":"Lincoln Paul Edwards","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26347476","display_name":"Loma Linda University","ror":"https://ror.org/04bj28v14","country_code":"US","type":"education","lineage":["https://openalex.org/I26347476"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lincoln P. Edwards","raw_affiliation_strings":["Center for Dental Research, Loma Linda University School of Dentistry, Loma Linda, United States; Department of Diagnostic and Biomedical Sciences, University of Texas School of Dentistry, Houston, United States. Electronic address: lpedwards@llu.edu","Center for Dental Research, Loma Linda University School of Dentistry, Loma Linda, United States","Department of Diagnostic and Biomedical Sciences, University of Texas School of Dentistry, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Dental Research, Loma Linda University School of Dentistry, Loma Linda, United States; Department of Diagnostic and Biomedical Sciences, University of Texas School of Dentistry, Houston, United States. Electronic address: lpedwards@llu.edu","institution_ids":["https://openalex.org/I26347476"]},{"raw_affiliation_string":"Center for Dental Research, Loma Linda University School of Dentistry, Loma Linda, United States","institution_ids":["https://openalex.org/I26347476"]},{"raw_affiliation_string":"Department of Diagnostic and Biomedical Sciences, University of Texas School of Dentistry, Houston, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5020840963"],"corresponding_institution_ids":["https://openalex.org/I26347476"],"apc_list":{"value":3290,"currency":"USD","value_usd":3290},"apc_paid":null,"fwci":0.575,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.5865376,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"66","issue":"6","first_page":"937","last_page":"945"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imidazoline-compounds","display_name":"imidazoline compounds","score":0.8820000290870667},{"id":"https://openalex.org/keywords/i1-imidazoline-receptor","display_name":"imidazoline I1 receptor","score":0.9629999995231628},{"id":"https://openalex.org/keywords/pc12-cells","display_name":"PC12 cells","score":0.8939999938011169},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6309999823570251},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8709999918937683},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.9980000257492065},{"id":"https://openalex.org/keywords/caspase-activation","display_name":"caspase activation","score":0.8320000171661377},{"id":"https://openalex.org/keywords/erk","display_name":"ERK","score":0.7749999761581421},{"id":"https://openalex.org/keywords/jnk","display_name":"JNK","score":0.9990000128746033},{"id":"https://openalex.org/keywords/p38-mapk","display_name":"p38 MAPK","score":0.9900000095367432},{"id":"https://openalex.org/keywords/efaroxan","display_name":"efaroxan","score":0.8799999952316284},{"id":"https://openalex.org/keywords/n-acetylcysteine","display_name":"N-acetylcysteine","score":0.8619999885559082},{"id":"https://openalex.org/keywords/z-vad-fmk","display_name":"z-VAD-fmk","score":0.8709999918937683}],"concepts":[{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.7601262331008911},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.7105244994163513},{"id":"https://openalex.org/C98424977","wikidata":"https://www.wikidata.org/wiki/Q25805","display_name":"Caspase","level":4,"score":0.6824216246604919},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.6182966232299805},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5678750276565552},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5362175703048706},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5252377986907959},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.5051823258399963},{"id":"https://openalex.org/C123605464","wikidata":"https://www.wikidata.org/wiki/Q1659850","display_name":"Imidazoline receptor","level":2,"score":0.4915848672389984},{"id":"https://openalex.org/C51551487","wikidata":"https://www.wikidata.org/wiki/Q2043632","display_name":"p38 mitogen-activated protein kinases","level":4,"score":0.47562673687934875},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46188801527023315},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26579058170318604},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.26036304235458374},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22927170991897583}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000840","descriptor_name":"Anisoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000840","descriptor_name":"Anisoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016716","descriptor_name":"PC12 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020169","descriptor_name":"Caspases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020928","descriptor_name":"Mitogen-Activated Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048031","descriptor_name":"JNK Mitogen-Activated Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048288","descriptor_name":"Imidazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D048288","descriptor_name":"Imidazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054755","descriptor_name":"Imidazoline Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.pharep.2014.06.003","doi":"https://doi.org/10.1016/j.pharep.2014.06.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.pharep.2014.06.003","pdf_url":null,"source":{"id":"https://openalex.org/S180401253","display_name":"Pharmacological Reports","issn_l":"1734-1140","issn":["1734-1140","2299-5684"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Reports","raw_type":"journal-article"},{"id":"pmid:25443718","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25443718","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W166455012","https://openalex.org/W187678234","https://openalex.org/W1840221795","https://openalex.org/W1964483580","https://openalex.org/W1965843200","https://openalex.org/W1979006721","https://openalex.org/W1984386298","https://openalex.org/W1997607044","https://openalex.org/W1997656209","https://openalex.org/W2000205368","https://openalex.org/W2006611341","https://openalex.org/W2007986629","https://openalex.org/W2014321807","https://openalex.org/W2019532222","https://openalex.org/W2024984581","https://openalex.org/W2037637880","https://openalex.org/W2042045241","https://openalex.org/W2048416518","https://openalex.org/W2052104385","https://openalex.org/W2053076131","https://openalex.org/W2059669347","https://openalex.org/W2070692423","https://openalex.org/W2077492829","https://openalex.org/W2080308960","https://openalex.org/W2082086364","https://openalex.org/W2095419284","https://openalex.org/W2135599444","https://openalex.org/W2148012276","https://openalex.org/W2164014399","https://openalex.org/W2168953051","https://openalex.org/W2172249877","https://openalex.org/W2182351390","https://openalex.org/W2258282831","https://openalex.org/W2323578154","https://openalex.org/W2410156448","https://openalex.org/W4211258630","https://openalex.org/W6607651178"],"related_works":["https://openalex.org/W2006611341","https://openalex.org/W578585009","https://openalex.org/W64368249","https://openalex.org/W2387445914","https://openalex.org/W2990874865","https://openalex.org/W1581040775","https://openalex.org/W2047810978","https://openalex.org/W2013201991","https://openalex.org/W2364314307"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1992801434","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
